Kemin’s immune-health ingredient BetaVia Complete now approved as Novel Food in Thailand
The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.
Kemin (Des Moines, IA) reports that the Thailand Food and Drug Administration (TFDA) has approved Kemin’s BetaVia Complete immune health ingredient, granting it Novel Food status. The algae-derived beta-glucan ingredient can now be used in food supplements for humans in Thailand at a daily dose of 375 mg.
“BetaVia Complete is derived from Euglena gracilis, Kemin’s proprietary strain of algae known for its high level of beta-1,3-glucan and protein content, which also contains essential fatty acids,” the company’s press release states.
BetaVia also holds regulatory approvals in the U.S. and European Union. The ingredient “helps train the body’s natural defenses, supports respiratory tract health, and protects intestinal barrier integrity,” the press release states.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
